Y-Intercept (HK)’s Elevance Health ELV Stock Holding History

Y-Intercept (HK)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2M	Buy	49,698 +21,198	+74%	+$7.86M	0.38%	28
2026 Q1	$8.34M	Buy	+28,500	New	+$9.37M	0.16%	149
2025 Q4	–	Sell	-5,522	Closed	-$1.78M	–	1665
2025 Q3	$1.78M	Sell	5,522 -18,025	-77%	-$5.61M	0.04%	679
2025 Q2	$9.16M	Buy	23,547 +22,745	+2,836%	+$9.15M	0.22%	83
2025 Q1	$349K	Sell	802 -12,339	-94%	-$4.95M	0.02%	851
2024 Q4	$4.85M	Buy	+13,141	New	+$5.5M	0.32%	54
2024 Q3	–	Sell	-5,085	Closed	-$2.76M	–	1444
2024 Q2	$2.76M	Buy	5,085 +207	+4%	+$109K	0.15%	165
2024 Q1	$2.53M	Buy	4,878 +2,117	+77%	+$1.05M	0.19%	123
2023 Q4	$1.3M	Sell	2,761 -1,947	-41%	-$900K	0.12%	227
2023 Q3	$2.05M	Sell	4,708 -791	-14%	-$359K	0.2%	134
2023 Q2	$2.44M	Buy	+5,499	New	+$2.54M	0.26%	82
2022 Q3	–	Sell	-3,882	Closed	-$1.87M	–	1055
2022 Q2	$1.87M	Buy	+3,882	New	+$1.92M	0.25%	95
2021 Q3	–	Sell	-1,024	Closed	-$391K	–	715
2021 Q2	$391K	Buy	+1,024	New	+$391K	0.1%	332

Other funds holding ELV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Y-Intercept (HK)'s ELV Position: Q2 2026 in Review

Y-Intercept (HK) increased its Elevance Health (ELV) stake by 74% in Q2 2026, buying an estimated $7.86M and bringing the position to 49,698 shares worth $19.2M. The position accounts for 0.38% of the portfolio, ranked #28.

Y-Intercept (HK) first reported a position in ELV in Q2 2021 and has held it in 13 quarters since. 293 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Y-Intercept (HK) held 49,698 shares of Elevance Health worth $19.2M as of Q2 2026.
Y-Intercept (HK) bought 21,198 Elevance Health shares in Q2 2026, an estimated $7.86M.
Elevance Health made up 0.38% of Y-Intercept (HK)'s portfolio in Q2 2026, its #28 holding.
Y-Intercept (HK) first reported a position in Elevance Health in Q2 2021 and has held it in 13 quarters since.
293 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.